PL2822568T3 - Zastosowania kompozycji kazeiny - Google Patents

Zastosowania kompozycji kazeiny

Info

Publication number
PL2822568T3
PL2822568T3 PL13757439T PL13757439T PL2822568T3 PL 2822568 T3 PL2822568 T3 PL 2822568T3 PL 13757439 T PL13757439 T PL 13757439T PL 13757439 T PL13757439 T PL 13757439T PL 2822568 T3 PL2822568 T3 PL 2822568T3
Authority
PL
Poland
Prior art keywords
casein compositions
casein
compositions
Prior art date
Application number
PL13757439T
Other languages
English (en)
Inventor
Aaron Calvin FANNING
Hasmukh Ambalal Patel
Johannes Schalk
Ramon Stafford HALL
Roger Richard Schwarzenbach
Sergey Yevgenievich UKRAINTSEV
Original Assignee
Fonterra Co-Operative Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49117099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2822568(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fonterra Co-Operative Group Limited filed Critical Fonterra Co-Operative Group Limited
Publication of PL2822568T3 publication Critical patent/PL2822568T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Water Supply & Treatment (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
PL13757439T 2012-03-09 2013-03-11 Zastosowania kompozycji kazeiny PL2822568T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261608858P 2012-03-09 2012-03-09
EP13757439.8A EP2822568B1 (en) 2012-03-09 2013-03-11 Uses of casein compositions
PCT/NZ2013/000035 WO2013133727A1 (en) 2012-03-09 2013-03-11 Uses of casein compositions

Publications (1)

Publication Number Publication Date
PL2822568T3 true PL2822568T3 (pl) 2020-11-16

Family

ID=49117099

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13757439T PL2822568T3 (pl) 2012-03-09 2013-03-11 Zastosowania kompozycji kazeiny

Country Status (13)

Country Link
US (3) US20150011468A1 (pl)
EP (1) EP2822568B1 (pl)
JP (1) JP6420156B2 (pl)
CN (1) CN104159592B (pl)
AU (1) AU2013202942B2 (pl)
DK (1) DK2822568T3 (pl)
ES (1) ES2811759T3 (pl)
HR (1) HRP20201197T1 (pl)
HU (1) HUE050010T2 (pl)
LT (1) LT2822568T (pl)
NZ (1) NZ700686A (pl)
PL (1) PL2822568T3 (pl)
WO (1) WO2013133727A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201602012RA (en) * 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
CN107404929B (zh) * 2014-12-26 2021-01-26 达能日尔维公司 包括容器和乳清蛋白的产品
CN122398856A (zh) * 2015-05-22 2026-07-17 艾尔牛奶有限公司 β-酪蛋白A2和抗氧化能力
TWI761487B (zh) * 2017-04-06 2022-04-21 日商明治股份有限公司 用於促進血中胺基酸濃度上升之發酵乳
WO2019086407A1 (en) 2017-10-30 2019-05-09 Frieslandcampina Nederland B.V. Protein-dense nutritional compositions for use in treating and/or preventing a condition linked to loss of muscle mass and/or strength
MX2021005925A (es) 2018-11-20 2021-06-30 Fonterra Cooperative Group Ltd Proceso y producto lacteo.
US20220295816A1 (en) * 2019-05-20 2022-09-22 Kirk Gibson RUMMEL, III Enhanced coffee or tea
CN115397247B (zh) * 2020-04-13 2026-05-26 合同酒精株式会社 发酵乳及其制造方法、以及脱磷酸乳
US20210352938A1 (en) * 2020-05-12 2021-11-18 Raymond L. Sullivan, JR. Novel drink
US20220030923A1 (en) * 2020-07-17 2022-02-03 Northern Innovations Holding Corp. Caffeine and Alpha Lipoic Acid Compositions for Enhanced Sensory Effects
IL276823A (en) * 2020-08-19 2022-03-01 Re Milk Ltd Casein formulations and their use
CN114304369A (zh) * 2020-09-29 2022-04-12 内蒙古伊利实业集团股份有限公司 一种乳清蛋白组合物及其制备方法和应用
US20220225640A1 (en) * 2021-01-19 2022-07-21 Alexia Ramos Multipurpose Beverage Composition
WO2022225770A1 (en) * 2021-04-19 2022-10-27 Abbott Laboratories High protein liquid nutritional compositions
CN116210914A (zh) * 2023-03-02 2023-06-06 中国农业大学 一种胶束酪蛋白-花色苷复合物粉体组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501675A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Translucent milk drink having a pH of 5.7 to 7.0 and a percentage transmission of at least 5% prepared by a cation exchange process
NZ501676A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Calcium-depleted milk protein products and use in cheese manufacture to reduce nugget-formation
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
NZ523394A (en) * 2002-12-24 2006-03-31 New Zealand Dairy Board Dairy protein processing and applications thereof
WO2010126353A1 (en) * 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
TWI519242B (zh) * 2010-01-29 2016-02-01 亞培公司 包含鈣hmb及可溶性蛋白質的營養乳劑
HUE057338T2 (hu) * 2010-07-16 2022-05-28 Fonterra Cooperative Group Ltd Tejtermék és eljárás

Also Published As

Publication number Publication date
LT2822568T (lt) 2020-09-10
WO2013133727A1 (en) 2013-09-12
CN104159592B (zh) 2018-10-19
EP2822568A1 (en) 2015-01-14
EP2822568A4 (en) 2015-11-11
DK2822568T3 (da) 2020-08-10
JP6420156B2 (ja) 2018-11-07
HRP20201197T1 (hr) 2020-11-13
AU2013202942A1 (en) 2013-09-26
US20170232063A1 (en) 2017-08-17
US20150011468A1 (en) 2015-01-08
AU2013202942B2 (en) 2016-05-12
JP2015509531A (ja) 2015-03-30
HUE050010T2 (hu) 2020-11-30
ES2811759T3 (es) 2021-03-15
CN104159592A (zh) 2014-11-19
US20190105371A1 (en) 2019-04-11
HK1205947A1 (en) 2015-12-31
NZ700686A (en) 2016-08-26
EP2822568B1 (en) 2020-06-17

Similar Documents

Publication Publication Date Title
HUE050010T2 (hu) Kazein készítmények alkalmazása
IL237604A0 (en) Compositions of enzalutamide
IL233649A0 (en) Preparations derived from chitosan
ME03413B (me) Kompozicije које sadrže peg i askorbat
GB2511197B (en) Compositions
ZA201503157B (en) Compositions
GB201209244D0 (en) Compositions
GB201501016D0 (en) Preparation of 18F-fluciclovine
GB201210800D0 (en) Compositions
GB201201287D0 (en) Compositions
GB201203597D0 (en) Skincare compositions
ZA201503062B (en) Compositions
ZA201503102B (en) Finafloxacin suspension compositions
ZA201407604B (en) Novel depilatory compositions
GB201220068D0 (en) Compositions
ZA201502542B (en) Compositions
ZA201406753B (en) Long acting compositions
GB201219973D0 (en) Compositions
GB201219962D0 (en) Compositions
GB201219980D0 (en) Compositions
TWI561248B (en) Peracid-generating compositions
GB201215519D0 (en) Novel compositions
GB201207804D0 (en) Novel compositions
GB201207496D0 (en) Novel compositions
EP2926813A4 (en) METFORMIN-Orlistat COMPOSITIONS